The subject expert committee (SEC) on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will meet soon to consider Serum Institute of India’s application for emergency use approval of its COVID19 vaccine, which is being developed in collaboration with Oxford University and pharmaceutical company Astra Zeneca.
This is a developing story, more details awaited.